The Portal of Geriatrics Online Education

Elder Care: A Resource for Interprofessional Providers: Amyloid Imaging for Alzheimer's Disease

CC BY-NC-SA

Elder Care: A Resource for Interprofessional Providers: Amyloid Imaging for Alzheimer's Disease

University of Arizona College of Medicine
Author(s):  
Philip H. Kuo, MD, Geoffrey L. Ahern, MD, Alex Hishaw MD
Sponsor: 
Donald W. Reynolds Foundation
Geriatric Education Center (GEC)
Geriatrics Workforce Enhancement Program (GWEP)
POGOe Id: 
21623
Date Posted: 
05/15/2013
Date Reviewed/Updated for Clinical Accuracy: 
12/30/2016
Abstract: 

Amyloid Imaging for Alzheimer's Disease  is one of a continuing series of practical, evidence based, Provider Fact Sheets which summarize key geriatric topics and provide clinically useful assessments and interventions. Initially developed for remote, rural clinical sites, they are useful for students and health care professionals from many fields and across a very broad range of health care settings.

Educational objectives: 
  1. Describe what is seen on a positive vs a negative florbetapir amyloid scan in Alzheimer’s disease
  2. List three situation in which a florbetapir amyloid scan may aid in determining if a patient has Alzheimer’s disease.
  3. State the most common dementia (other than Alzheimer’s disease) that may have a positive florbetapir amyloid scan
Additional information/Special implementation requirements or guidelines: 

Subscribers to POGOe are free to reprint Elder Care on their own stationery or in other publications without obtaining specific permission, so long as:

  1. Content is not changed,
  2. No one is charged a fee to use or read the publication,
  3. Authors and their affiliated institutions are noted without change, and
  4. The reprint includes the following statement: “Reprinted courtesy of the Arizona Reynolds Program of Applied Geriatrics and the Arizona Geriatric Education Center."
Conflict of Interest Disclosure: 
Yes, I (we) have conflict of interest to disclose.
Conflict Description: 
Kuo: Paid by Lilly to speak on Amyvid Ahern: Participated in one of the original clinical trials leading to the development of AV-45 (now Amyvid) by AVID Pharmaceuticals, prior to that company's acquisition by Lilly
Contact Person/Corresponding Author:
Suggested Citation:
Phillip H. Kuo MD; and Geoffrey L. Ahern MD. Elder Care: A Resource for Interprofessional Providers: Amyloid Imaging for Alzheimer's Disease. POGOe - Portal of Geriatrics Online Education; 2013 Available from: https://pogoe.org/productid/21623